Piotr Czempik: Anti-Xa-Guided Enoxaparin Prophylaxis in Extreme Obesity
Piotr Czempik, Chair of Department of Anesthesiology and Intensive Care at Medical University of Silesia, shared on LinkedIn about recent article he and his colleague co-authored, published in Journal of Transfusion Medicine and Hemostasis, adding:
”How to provide safe and effective antithrombotic prophylaxis in extremely obese patients?
Happy to share our latest case report addressing this challenging critical care issue.
What the paper covers:
Patients >150–200 kg often fail to reach target anti‑Xa levels with standard low-molecular-weight heparin (LMWH) dosing.
In our 200‑kg ICU patient, we implemented a fully individualized strategy using:
- weight‑based enoxaparin dosing
- twice‑daily administration
- serial anti‑Xa monitoring
- additional ROTEM analysis for anticoagulation interpretation
- dynamic dose adjustment to maintain intermediate‑intensity antithrombotic prophylaxis
The result: effective VTE prevention with no bleeding events, demonstrating the value of personalized anticoagulation in this high‑risk population.
Key insight:
An initial enoxaparin dose of 0.3 mg/kg SC BID, followed by anti‑Xa–guided adjustment, may offer a rational and safer approach for ICU patients with extreme obesity.”
Title: Optimizing prophylactic low-molecular-weight heparin anticoagulation in a 200-kg ICU patient: a case report
Authors: Piotr Filip Czempik, Dariusz Bednarski
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 13, 2026, 17:28Jim Hoffman: New Potential Predictive Biomarker for Lupus Nephritis
-
Sep 13, 2026, 17:08W. Alberto Sifuentes Giraldo: Urticarial Vasculitis Clinical Features, Systemic Involvement, and Treatment
-
Sep 13, 2026, 16:58Let’s Debunk Some Myths about Blood in SCD – ASCO
-
Sep 13, 2026, 16:56William Wallace: A Magnesium Ion Decides Whether Your Brain Learns or Not
-
Sep 13, 2026, 16:54Meet NBDF’s 2026 Excellence Fellowship Recipients – National Bleeding Disorders Foundation
-
Sep 13, 2026, 16:52Kaloyan Takov: Native Lp(a) Carries a Distinct Triglyceride Signature Linked to Cardiovascular Disease
-
Sep 13, 2026, 16:51Axay Tomar: How Simulation-Based Education Shapes Safer Transfusion Practices
-
Sep 13, 2026, 16:51Edina Cenko: AZURE-HeFH Highlights the LDL-C Treatment Gap in HeFH
-
Sep 13, 2026, 16:49William Aird: Why Is LDH Elevated In Splenic Infarction?